Imugene Limited Company Information
Imugene Limited's employee growth, exchange listings and data sources
Key Information
- Name: Imugene Limited
- Ticker: IMU
- Exchange: ASX
- Founded: NaN
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: AU$297.490m
- Shares Outstanding: 7.44b
- Website: https://www.imugene.com
Location
- Imugene Limited
- 4-6 Bligh Street
- Suite 12.01, Level 12
- Sydney
- New South Wales
- 2000
- Australia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| IMU | ASX (Australian Securities Exchange) | Yes | Ordinary Shares | AU | AUD | Sep 2002 |
| IUGN.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Sep 2002 |
| IMU | CHIA (Chi-X Australia) | Yes | Ordinary Shares | AU | AUD | Sep 2002 |
| ILA | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Sep 2002 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/21 14:26 |
| End of Day Share Price | 2024/11/21 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.